Latest Articles

Publication Date
Recurrent IVF Failure isn’t the End of Journey; Personalised Treatment is Improving Success Rates: Fertility Experts - IndiaMedToday

Recurrent IVF Failure isn’t the End of Journey; Personalised Treatment is Improving Success Rates: Fertility Experts IndiaMedToday

Published: July 25, 2026, 4:03 a.m.
Recurrent IVF Failure isn’t the End of Journey ; Personalised Treatment is Improving Success Rates: Fertility Experts - 5 Dariya News

Recurrent IVF Failure isn’t the End of Journey ; Personalised Treatment is Improving Success Rates: Fertility Experts 5 Dariya News

Published: July 23, 2026, 7:34 a.m.
Recurrent IVF Failure isn’t the End of Journey; Personalised Treatment is Improving Success Rates: Fertility Experts - Modern Ghana

Recurrent IVF Failure isn’t the End of Journey; Personalised Treatment is Improving Success Rates: Fertility Experts Modern Ghana

Published: July 22, 2026, 1:11 p.m.
A rare case of life-threatening haematochezia in pregnancy associated with decidualized rectal mucosal endometriosis.

To report and emphasize the difficulty in diagnosis and management of acute gastrointestinal bleeding due to recurrent endometriosis in pregnancy.

Published: July 22, 2026, midnight
Assessing the female urogenital-rectal axis microbiome: focus on endometriosis and recurrent implantation failure.

Emerging evidence suggests microbial dysbiosis may contribute to gynaecological pathologies, including endometriosis and recurrent implantation failure (RIF). The vaginal microbiome is well-characterised, with Lactobacillus-dominance as a hallmark of health, yet …

Published: July 21, 2026, midnight
Right-Sided Mixed Intrinsic and Extrinsic Ureteral Endometriosis Leading to a Nonfunctioning Kidney: A Case Report.

Ureteral endometriosis is a rare form of urinary tract endometriosis that may cause silent ureteral obstruction and irreversible renal damage. Mixed intrinsic and extrinsic ureteral involvement is uncommon, and right-sided …

Published: July 17, 2026, midnight
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - BioSpace

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy BioSpace

Published: July 15, 2026, 3:11 p.m.
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - Business Wire

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy Business Wire

Published: July 15, 2026, 10:45 a.m.
Beyond growing teratoma syndrome: post-treatment manifestations and diagnostic challenges following ovarian immature teratoma.

Growing teratoma syndrome (GTS) is a rare condition classically associated with platinum-based chemotherapy for malignant ovarian germ cell tumors. However, post-treatment findings following ovarian immature teratoma may represent a broader …

Published: July 14, 2026, midnight
Early-life exposures and risk of multiple gynecological diseases: evidence from a large community-based study of 272,706 women.

Early-life exposures may influence long-term reproductive health, but comprehensive population-based evidence remains limited. This study aimed to evaluate the associations between six early-life factors (long-term/recurrent antibiotic use [LRAU], birth weight, …

Published: July 2, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!